10-K: Elite Health Systems Inc. 10-K: Medicare Advantage Expansion

Elite Health Systems Inc. files its 2025 10-K, detailing progress in its Medicare Advantage plan development and the acquisition of Physician Support Systems Inc.

Summary

• Elite Health Systems Inc. (EHSI) has filed its annual report for the fiscal year ended December 31, 2025.
• The company is focused on developing Medicare Advantage plans and offering healthcare services, primarily for senior and special needs groups.
• EHSI operates through its subsidiaries, Elite Health Plan, Inc. (Elite Health) and Physician Support Systems Inc. (PSS).
• Elite Health received approval in 2025 to operate a Medicare Advantage plan in California counties Los Angeles, Riverside, and San Bernardino, beginning operations in October 2025.
• The company acquired PSS in November 2025 to enhance its healthcare management solutions capabilities.
• EHSI is pursuing expansion into specialized plans like Chronic Condition Special Needs Plans (C-SNPs) and is exploring geographic expansion.
• The company reported a net loss of $7,804,000 for 2025, compared to $2,055,000 in 2024.
• Significant investments were made in software development and the PSS acquisition.
• The company raised approximately $3.7 million in a private placement in 2025 and $4.8 million in 2024 to fund operations and growth.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the increased net loss, growing accumulated deficit, and substantial doubt regarding the company's ability to continue as a going concern, despite strategic progress in obtaining licenses and making acquisitions.

Positives

• Received Knox-Keene license and CMS approval to operate a Medicare Advantage plan in California in 2025.
• Began onboarding Medicare Advantage plan members in October 2025.
• Acquired Physician Support Systems Inc. (PSS) in November 2025, adding revenue-generating operations and healthcare management solutions.
• Secured $3.7 million in private placement funding in 2025 and $4.8 million in 2024 to support business development.
• Filed a 2027 C-SNP Application with CMS in February 2026, indicating a strategic move towards specialized plans.
• Management believes its plans alleviate substantial doubt regarding the company's ability to continue as a going concern.

Negatives

• Reported a net loss of $7,804,000 for the fiscal year ended December 31, 2025, an increase from the $2,055,000 net loss in 2024.
• The company has an accumulated deficit of $12,249,000 as of December 31, 2025.
• The company has no operating history in Medicare plans prior to the current fiscal year.
• Significant investments in software development and acquisition costs led to increased net cash used in investing activities.
• The company has no access to a line of credit or other readily available sources of capital, raising substantial doubt about its ability to continue as a going concern.
• Goodwill impairment of $3,978,000 was recorded related to the PSS acquisition due to a customer loss.

Risks

• The company's success is critically dependent on its ability to grow subscriber levels and provide high-quality patient care efficiently and cost-effectively.
• Future capital requirements may not be available on acceptable terms, potentially impairing business and financial condition, and raising concerns about the ability to continue as a going concern.
• Failure to maintain Medicare Advantage licenses, acquire sufficient managed health consumers, or expand the product and service portfolio could significantly impair business and operations.
• Reliance on third-party service providers introduces risks if these parties fail to satisfy their obligations, including data security and protection.
• The company operates in highly competitive markets dominated by larger entities with significantly more resources.
• Cybersecurity threats, data breaches, or system disruptions could lead to significant costs, liability, and reputational harm.
• Failure to appropriately set premiums or effectively manage medical costs could negatively affect profitability, results of operations, and cash flows.
• The launch and development costs of Medicare Advantage plans, or failure to attain profitability in new businesses, could negatively affect results of operations.
• Reimbursement by third-party payors, including Medicare, is complex and subject to delays, uncertainties, and potential disagreements.
• CMS's projected near-flat net average payment update for Medicare Advantage plans in 2027, despite a later improved increase, indicates a constrained reimbursement outlook.
• The company is subject to extensive fraud and abuse laws, which could lead to lawsuits, claims, and penalties.
• Medical liability claims could result in significant expenses and damages, potentially exceeding insurance coverage.
• Restrictions on the ability to obtain funds from regulated subsidiaries could adversely affect the ability to reinvest in the business or return capital to shareholders.
• The common stock is thinly traded on the OTCQB marketplace, leading to high volatility and potential difficulty in selling shares.
• The company has disclosed material weaknesses in its financial controls and procedures due to limited resources and segregation of duties.

Future Outlook

The company expects to expand its Medicare Advantage footprint geographically and through specialized products like C-SNP plans. It may also pursue acquisitions of physician groups and management service organizations, and strategic partnerships. Management believes its current plans and capital raising efforts will allow it to continue as a going concern for at least the next twelve months, but acknowledges that future capital availability on favorable terms is not assured.

Management Comments

• "Despite these industry challenges, we believe the continued expansion of the Medicare Advantage program and the broader shift toward value-based care reimbursement models continue to create meaningful opportunities for us to grow our business as well as partner with physicians and expand our integrated care platform."
• "Management believes its plan alleviates the substantial doubt and that it will be successful in its planned business initiatives and will be able to continue as a going concern through at least the next twelve months."
• "We believe the Acquisition will strengthen the Company's health experience, access to providers and management team."
• "PSS is an operating business with revenue, creating a stronger set of financial statements of the Company."

Industry Context

StockSavvy.ai notes that Elite Health Systems Inc. is operating within the rapidly growing Medicare Advantage market, which is seeing increased enrollment and a shift towards value-based care. However, the industry faces regulatory scrutiny and a constrained reimbursement outlook, as indicated by CMS's projected payment updates. The company's strategy to focus on specialized plans like C-SNPs and geographic expansion aligns with industry trends aimed at improving clinical outcomes and managing costs.

Comparison to Industry Standards

• The Medicare Advantage market is dominated by major players like UnitedHealth Group and Humana, which together account for nearly half of all Medicare Advantage enrollees nationwide.
• The Kaiser Family Foundation reported that C-SNP Plan enrollment rose by approximately 71% from 2024 to 2025, accounting for about three-quarters of SNP enrollment growth in that period, highlighting the growth potential in specialized plans.
• CMS's CY 2027 Medicare Advantage and Part D Advance Notice projected a near-flat net average payment update of 0.09%, which was later improved to 2.48% in the Final Advance Notice. This reflects a constrained reimbursement environment compared to historical averages.
• Profit margins in the managed health industry are generally low, often in the single digits, which Elite Health Systems Inc. acknowledges as a factor impacting its operations.

Legal Proceedings

• The company is subject to lawsuits, investigations, and potential claims arising out of the ordinary conduct of its business, but is not currently involved in any material litigation.

Related Party Transactions

• The Company used the services of PSS until its acquisition in November 2025. Dr. Jeereddi, CEO, owned 90% of PSS, and his immediate family member served as an executive officer of PSS.
• The acquisition of PSS involved issuing 3,158,000 shares of common stock to PSS shareholders, including Dr. Jeereddi.
• All revenue of $1,024,000 reported for fiscal 2025 from PSS comes from related parties, as PSS customers had familial or management relationships with Dr. Jeereddi.

Stakeholder Impact

• Shareholders: Potential dilution from future equity financings; stock price volatility due to thin trading; potential loss of investment if the company cannot continue as a going concern.
• Employees: The company had 87 employees at December 31, 2025, primarily within the PSS subsidiary.
• Customers (Medicare beneficiaries): Access to Medicare Advantage plans in California; potential impact on quality of care and provider access based on network development and cost management.
• Providers: Potential for new patient volume and participation in a growing platform; reliance on PSS for healthcare management solutions.
• Creditors: Substantial doubt about the company's ability to continue as a going concern may impact repayment of any debt.

Next Steps

• Expand Medicare Advantage footprint geographically and through specialized products like C-SNP plans.
• Pursue acquisitions of physician groups and management service organizations.
• Engage in strategic partnerships with physician organizations, health systems, and technology companies.
• Continue to raise capital through equity or debt financings in fiscal 2026.
• Manage activities and expenses to align with cash resources on hand and expected capital raises.

Key Dates

Recommendation

The company has made significant strategic progress in obtaining licenses and acquiring an operating business, which are positive developments. However, the substantial net loss, growing accumulated deficit, and the stated doubt about its ability to continue as a going concern present significant risks. The need for substantial future capital raises also introduces dilution risk. Therefore, a 'hold' recommendation is appropriate, pending further clarity on its ability to achieve profitability and secure necessary funding without excessive dilution.

Keywords

Elite Health Systems, Medicare Advantage, Form 10-K, Healthcare, Health Plan, Physician Support Systems, CMS, California, Financial Report, Annual Report